SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001260
Filing Date
2019-09-16
Accepted
2019-09-16 17:12:16
Documents
12
Period of Report
2019-09-16
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529483_8k.htm   iXBRL 8-K 22574
  Complete submission text file 0001410578-19-001260.txt   191083

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA irwd-20190916.xsd EX-101.SCH 3205
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20190916_lab.xml EX-101.LAB 33476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20190916_pre.xml EX-101.PRE 21971
13 EXTRACTED XBRL INSTANCE DOCUMENT tv529483_8k_htm.xml XML 3497
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 191095245
SIC: 2834 Pharmaceutical Preparations